Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2

Baris Turkbey, Andrew B. Rosenkrantz, Masoom A. Haider, Anwar R. Padhani, Geert Villeirs, Katarzyna Macura, Clare M. Tempany, Peter L. Choyke, Francois Cornud, Daniel J. Margolis, Harriet C. Thoeny, Sadhna Verma, Jelle Barentsz, Jeffrey C. Weinreb

Research output: Contribution to journalReview article

Abstract

The Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) was developed with a consensus-based process using a combination of published data, and expert observations and opinions. In the short time since its release, numerous studies have validated the value of PI-RADS v2 but, as expected, have also identified a number of ambiguities and limitations, some of which have been documented in the literature with potential solutions offered. To address these issues, the PI-RADS Steering Committee, again using a consensus-based process, has recommended several modifications to PI-RADS v2, maintaining the framework of assigning scores to individual sequences and using these scores to derive an overall assessment category. This updated version, described in this article, is termed PI-RADS v2.1. It is anticipated that the adoption of these PI-RADS v2.1 modifications will improve inter-reader variability and simplify PI-RADS assessment of prostate magnetic resonance imaging even further. Research on the value and limitations on all components of PI-RADS v2.1 is strongly encouraged.

Original languageEnglish (US)
JournalEuropean Urology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Information Systems
Prostate
Expert Testimony
Magnetic Resonance Imaging
Research

Keywords

  • Prostate cancer
  • Prostate Imaging Reporting and Data System Version 2
  • Prostate Imaging Reporting and Data System Version 2.1

ASJC Scopus subject areas

  • Urology

Cite this

Prostate Imaging Reporting and Data System Version 2.1 : 2019 Update of Prostate Imaging Reporting and Data System Version 2. / Turkbey, Baris; Rosenkrantz, Andrew B.; Haider, Masoom A.; Padhani, Anwar R.; Villeirs, Geert; Macura, Katarzyna; Tempany, Clare M.; Choyke, Peter L.; Cornud, Francois; Margolis, Daniel J.; Thoeny, Harriet C.; Verma, Sadhna; Barentsz, Jelle; Weinreb, Jeffrey C.

In: European Urology, 01.01.2019.

Research output: Contribution to journalReview article

Turkbey, B, Rosenkrantz, AB, Haider, MA, Padhani, AR, Villeirs, G, Macura, K, Tempany, CM, Choyke, PL, Cornud, F, Margolis, DJ, Thoeny, HC, Verma, S, Barentsz, J & Weinreb, JC 2019, 'Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2', European Urology. https://doi.org/10.1016/j.eururo.2019.02.033
Turkbey, Baris ; Rosenkrantz, Andrew B. ; Haider, Masoom A. ; Padhani, Anwar R. ; Villeirs, Geert ; Macura, Katarzyna ; Tempany, Clare M. ; Choyke, Peter L. ; Cornud, Francois ; Margolis, Daniel J. ; Thoeny, Harriet C. ; Verma, Sadhna ; Barentsz, Jelle ; Weinreb, Jeffrey C. / Prostate Imaging Reporting and Data System Version 2.1 : 2019 Update of Prostate Imaging Reporting and Data System Version 2. In: European Urology. 2019.
@article{c8613ebce58745ed80a93d115625e652,
title = "Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2",
abstract = "The Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) was developed with a consensus-based process using a combination of published data, and expert observations and opinions. In the short time since its release, numerous studies have validated the value of PI-RADS v2 but, as expected, have also identified a number of ambiguities and limitations, some of which have been documented in the literature with potential solutions offered. To address these issues, the PI-RADS Steering Committee, again using a consensus-based process, has recommended several modifications to PI-RADS v2, maintaining the framework of assigning scores to individual sequences and using these scores to derive an overall assessment category. This updated version, described in this article, is termed PI-RADS v2.1. It is anticipated that the adoption of these PI-RADS v2.1 modifications will improve inter-reader variability and simplify PI-RADS assessment of prostate magnetic resonance imaging even further. Research on the value and limitations on all components of PI-RADS v2.1 is strongly encouraged.",
keywords = "Prostate cancer, Prostate Imaging Reporting and Data System Version 2, Prostate Imaging Reporting and Data System Version 2.1",
author = "Baris Turkbey and Rosenkrantz, {Andrew B.} and Haider, {Masoom A.} and Padhani, {Anwar R.} and Geert Villeirs and Katarzyna Macura and Tempany, {Clare M.} and Choyke, {Peter L.} and Francois Cornud and Margolis, {Daniel J.} and Thoeny, {Harriet C.} and Sadhna Verma and Jelle Barentsz and Weinreb, {Jeffrey C.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.eururo.2019.02.033",
language = "English (US)",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",

}

TY - JOUR

T1 - Prostate Imaging Reporting and Data System Version 2.1

T2 - 2019 Update of Prostate Imaging Reporting and Data System Version 2

AU - Turkbey, Baris

AU - Rosenkrantz, Andrew B.

AU - Haider, Masoom A.

AU - Padhani, Anwar R.

AU - Villeirs, Geert

AU - Macura, Katarzyna

AU - Tempany, Clare M.

AU - Choyke, Peter L.

AU - Cornud, Francois

AU - Margolis, Daniel J.

AU - Thoeny, Harriet C.

AU - Verma, Sadhna

AU - Barentsz, Jelle

AU - Weinreb, Jeffrey C.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) was developed with a consensus-based process using a combination of published data, and expert observations and opinions. In the short time since its release, numerous studies have validated the value of PI-RADS v2 but, as expected, have also identified a number of ambiguities and limitations, some of which have been documented in the literature with potential solutions offered. To address these issues, the PI-RADS Steering Committee, again using a consensus-based process, has recommended several modifications to PI-RADS v2, maintaining the framework of assigning scores to individual sequences and using these scores to derive an overall assessment category. This updated version, described in this article, is termed PI-RADS v2.1. It is anticipated that the adoption of these PI-RADS v2.1 modifications will improve inter-reader variability and simplify PI-RADS assessment of prostate magnetic resonance imaging even further. Research on the value and limitations on all components of PI-RADS v2.1 is strongly encouraged.

AB - The Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) was developed with a consensus-based process using a combination of published data, and expert observations and opinions. In the short time since its release, numerous studies have validated the value of PI-RADS v2 but, as expected, have also identified a number of ambiguities and limitations, some of which have been documented in the literature with potential solutions offered. To address these issues, the PI-RADS Steering Committee, again using a consensus-based process, has recommended several modifications to PI-RADS v2, maintaining the framework of assigning scores to individual sequences and using these scores to derive an overall assessment category. This updated version, described in this article, is termed PI-RADS v2.1. It is anticipated that the adoption of these PI-RADS v2.1 modifications will improve inter-reader variability and simplify PI-RADS assessment of prostate magnetic resonance imaging even further. Research on the value and limitations on all components of PI-RADS v2.1 is strongly encouraged.

KW - Prostate cancer

KW - Prostate Imaging Reporting and Data System Version 2

KW - Prostate Imaging Reporting and Data System Version 2.1

UR - http://www.scopus.com/inward/record.url?scp=85063010991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063010991&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2019.02.033

DO - 10.1016/j.eururo.2019.02.033

M3 - Review article

C2 - 30898406

AN - SCOPUS:85063010991

JO - European Urology

JF - European Urology

SN - 0302-2838

ER -